HUSSEIN TAWBI to Proto-Oncogene Proteins c-met
This is a "connection" page, showing publications HUSSEIN TAWBI has written about Proto-Oncogene Proteins c-met.
Connection Strength
0.158
-
Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors. Cancer Chemother Pharmacol. 2021 10; 88(4):643-654.
Score: 0.158